Medicenna Therapeutics

Profile

Medicenna Therapeutics is a clinical-stage immunotherapy company engineering next-generation cytokine therapies for cancer and immune-mediated diseases. Its pipeline includes Bizaxofusp, a Phase 3-ready therapy for recurrent glioblastoma which doubled median survival in Phase 2b; MDNA11, a long-acting IL-2 Superkine in two Phase 1/2 clinical trials; and MDNA113, a tumor-targeted PD-1 x IL-2 program which the Company anticipates advancing into a Phase 1 trial in 2027.

Medicenna Therapeutics logo
medicenna.com

Contact

Event details

Date: November 9 - 11, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

25 in total
  • 20/20 OptimEyes Technologies
    20/20 OptimEyes Technologies is developing OPT-101, a sustained-release glaucoma eye drop designed to reduce…
  • Acanthus Pharma Services Inc.
    APS Pharma™ is a Canadian innovation-focused specialty chemistry…
  • AlloWide Health
    AlloWide Health is an Ontario-based biotechnology company developing innovative solutions to improve the…
  • Altis Labs
    Altis Labs is the AI endpoint company accelerating clinical trials. Altis has trained proprietary…
  • BioBackers
    Lumerate’s investor intelligence brand, tracks global life science deal flow to reveal behavioral signals that…
  • BioScript Solutions
    BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care. BioScript…
  • Bough Bioscience
    Bough Bio is a pre-clinical stage company focused on decoding the molecular biology of senescent cells to unlock…
  • Dalriada
    Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets…
  • Intrepid Labs
    Drug formulation has the power to transform promising compounds into life-saving therapies, yet this step is…
  • JN Nova Pharma
    JN Nova Pharma is a Canadian biotechnology company developing a proprietary platform technology to…
  • Kanata Bio
    Over 30% of organ transplant patients have complications due to CMV. Kanata…
  • Medicenna Therapeutics
    Medicenna Therapeutics is a clinical-stage immunotherapy company engineering next-generation cytokine therapies…
  • Pattern Pharma Inc.
    Pattern’s patented PPI-100 activates innate immunity against cancers…
  • PlantForm Corporation
    PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty…
  • ProteinQure Inc.
    ProteinQure has built the best computational platform for designing peptides for extra-cellular targets. Its lead…
  • Q&C Services
    Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural…
  • QurCan Therapeutics
    QurCan Therapeutics is advancing the next wave of genetic medicines for CNS…
  • Rhythm Biotherapeutics Inc.
    Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation…
  • Singularity Pharma
    Singularity Pharma is a drug discovery business developing novel therapeutics for…
  • Specific Biologics
    Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class…
  • Spiderwort Biotechnologies
    Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number…
  • TheraVac Biologics
    TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for…
  • Transpharmation
    Transpharmation is a contract research organisation led by scientists. Recognised by drug developers worldwide…
  • Virano Therapeutics
    Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the…
  • YYZ Pharmatech Inc.
    YYZ Pharmatech Inc. (YYZ) is a deep tech company endeavoring to profoundly progress new medicine for…